Pinetree Therapeutics, Inc.

About Pinetree Therapeutics, Inc.

PineTree Therapeutics Inc. is a preclinical stage biotechnology company focused on pioneering disruptive therapies for oncology and other diseases, aiming to address unmet medical needs through targeted biologic therapeutics.

Products & Services

AbReptor:A first and best-in-class, transformative, modular bi-specific and multi-specific antibody platform designed to degrade membrane-bound and extracellular proteins.

TAER-TAB:A bispecific antibody (bsAb) platform targeting a unique, difficult-to-target receptor present on cancer cells across various cancer types such as lung, breast, pancreatic, cervical, colon, kidney, ovarian, and stomach cancers.

Specialties

Oncology Biologic Therapeutics Antibody Platforms Drug Discovery and Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 47000000 MR: - FA: $47 million FAN: 47000000	D: 2025-10-28 FD: 2025-10-28	11 investors
2	RT: Series A T: - FT: Series A	A: 17000000 MR: - FA: $17 million FAN: 17000000	D: 2024-07-30 FD: 2024-07-30	7 investors

Series B Latest

2025-10-28

$47.0M

11 investors (Pro only)

Series A 2024-07-30

$17.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Hojuhn Song

Co-Founder and Chief Executive Officer

S

Steve Gillies

Chief Scientific Officer

P

Paul Rennert

Member, SAB

P

Pamela A. Trail

Member, SAB

H

Ho-Juhn Song

Co-Founder and Chief Executive Officer

C

Clemens Reinshagen

Executive Director of Corporate Development & Translational Research

View 7 more team members with Pro

Unlock Full Team Directory

Recent News